Dexcom
Health Care
62
out of 100. Number 103 of 512, counting from the worst.
Where Dexcom does well
- Renewals 2 of 20. Few problems found.
- The site honors Global Privacy Control automatically and offers a visible cookie-consent shield icon to withdraw consent for collection/sharing at the browser level.
- Dexcom states it does not 'sell' any consumer data 'in the traditional sense for monetary compensation' and does not sell the personal information of known minors under 18 for targeted advertising.
- Arbitration exempts disputes qualifying for small claims court and is disapplied for EU/Austrian consumers; country-specific terms give Korean users email notice of changes.
- Privacy rights requests have a dedicated portal, toll-free phone line, and written-request channels, with an explicit no-discrimination clause for exercising rights and a right to appeal denied requests to the state attorney general.
Any dispute with Dexcom (except small-claims-eligible ones) goes to private arbitration, not a jury trial, and you cannot join or file a class action.
The fine print
6 clauses and findings from the draft archive, dated 1 October 2026. The plain English comes first; the small print is the company's own words. None of these has been checked yet.
-
Any dispute with Dexcom (except small-claims-eligible ones) goes to private arbitration, not a jury trial, and you cannot join or file a class action. No opt-out mechanism is offered anywhere in the Terms.
WILL BE RESOLVED THROUGH FINAL AND BINDING ARBITRATION BEFORE A NEUTRAL ARBITRATOR INSTEAD OF IN A COURT BY A JUDGE OR JURY, AND YOU AGREE THAT DEXCOM AND YOU ARE EACH WAIVING THE RIGHT TO TRIAL BY A JURY. YOU AGREE THAT ANY ARBITRATION UNDER THIS AGREEMENT WILL TAKE PLACE ON AN INDIVIDUAL BASIS. YOU FURTHER AGREE THAT CLASS ARBITRATIONS AND CLASS ACTIONS ARE NOT PERMITTED, AND THAT YOU ARE AGREEING TO GIVE UP THE ABILITY TO PARTICIPATE IN A CLASS ACTION.
-
Dexcom admits its data-sharing with ad networks and social networks legally counts as a 'sale' of your personal data for behavioral advertising in some states; opting out is left to you and depends on your state's law.
Our disclosure of Personal Data to the following categories of third parties qualifies as the “sale” of Personal Data or the sharing or processing of Personal Data for the purpose of displaying advertisements that are selected based on Personal Data obtained or inferred over time from an individual’s activities across businesses or distinctly-branded websites, applications, or other services (otherwise known as “targeted advertising” or “cross-context behavioral advertising”) under certain privacy laws: - advertising networks - social networks
Dexcom Privacy Notice, “Personal Data Disclosures, Sales and Targeted Advertising”
-
Even your consumer health data — which the policy defines to include glucose-relevant health info and ML-inferred health attributes — may be used for cross-context behavioral advertising under 'certain limitations' that are never spelled out.
We may process and or use this information collected online and offline (including with your consent where required by Consumer Health Privacy Laws) for the following purposes: ... providing advertising and marketing services including for cross-context behavioral advertising where certain limitations are met
-
Dexcom can rewrite the contract and just post it on its website; if you keep using your glucose monitor for a week without objecting, you've 'agreed.' If you disagree, your only stated remedy is to stop using the product.
subject to applicable law, DexCom can change the terms of this Agreement by notifying you of such changes by any reasonable means, including by posting a notice of new terms to our Website. Your clicking “accept” to the new terms or your continued use of any DexCom Product, DexCom Service or Software App, for seven (7) days without objecting to the new terms, after any such change is acceptance of the new terms.
-
On termination Dexcom can wipe your account data immediately with no access window for you — yet if you come back, it quietly admits it may still hold your personal (health) data and will re-link it to you. The Privacy Notice meanwhile sets no fixed retention periods at all.
if your use of a Software App or DexCom Service is terminated for any reason, we may, without liability to you or any third party, immediately deactivate or delete your user name, password and account, and all associated materials (including Personal Information), without any obligation to provide any further access to such materials. ... If you later re-activate your account, and we have retained your Personal Information, we would re-associate your retained Personal Information with your newly re-activated account
-
No matter what goes wrong with the product, services, or this contract, Dexcom caps its total liability at $500 — for a medical glucose-monitoring device, and §8.8 adds that your 'sole and exclusive remedy' for dissatisfaction is to stop using it.
NONE OF THE DEXCOM PARTIES SHALL BE LIABLE FOR TOTAL DAMAGES FOR ALL CLAIMS ARISING FROM OR RELATING TO THIS AGREEMENT, DEXCOM PRODUCTS, DEXCOM SERVICES AND/OR SOFTWARE APPS IN AN AGGREGATE AMOUNT GREATER THAN $500.
How these were found
Terms of Use effective date shown on the page as January 26, 2023 (still posted as current on Oct 1, 2026); Privacy Notice marked 'Last Updated October, 2025'; WA/NV Consumer Health Data Privacy Policy effective July 22, 2024. All three documents were fetched directly from dexcom.com on Oct 1, 2026 (no mirrors needed). Dexcom's region-specific subscription programs (e.g., Dexcom ONE Flexi Subscription) have their own local terms and were not found in the main US Terms of Use, so no auto-renew clauses were assessed — the autorenew score reflects that absence. Quotes are verbatim from the documents.
These notes come from the original draft and are not independent verification.